This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundObesity is a global epidemic and a major riskfactor for cardiovasculardiseases. Laparoscopic sleeve gastrectomy (LSG) is an effective bariatric surgery, but its effect on cardiac functions remains unclear.
When it comes to cardiovasculardisease, two of the biggest riskfactors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. The greater the number of particles the artery wall is exposed to over time, the higher the risk of atherosclerosis and a heart attack 2.
Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovasculardiseases and thrombotic events. The primary outcome was to estimate the prevalence of cardiovascularriskfactors in patients with hemophilia compared to the general population.
When I asked the readers of this newsletter about their experience of trying to get a comprehensive cardiovascularrisk assessment, the general feeling I got back was one of frustration. The majority of readers here are middle-aged and concerned about their future risk of heart disease. So, no excuses there.
as BMI increased by category, and it prevailed more frequently among women and older people regardless of their BMI status. kg/m2), normal weight (18.524 kg/m2), overweight (2428 kg/m2), and obese (>28 kg/m2). kg/m2), normal weight (18.524 kg/m2), overweight (2428 kg/m2), and obese (>28 kg/m2).
Hypertensive disorders of pregnancy as a riskfactor for heart failure. BMI, body mass index; CV, cardiovascular; CVD, cardiovasculardisease; HELLP, haemolysis, elevated liver enzymes, low platelet count.
Exercise prevents and reverses cardiovasculardisease, but whether high-intensity exercise training (HIIT) is safe and effective for adults after minimally invasive heart surgery is unknown. Exercise is a wonder drug for cardiovasculardisease (CVD) prevention and reversal. Cardiac rehab works wonders.
It is currently unknown if these associations are confounded by pleiotropic effects of the instrumental variables (IV) on cardiovasculardisease (CVD) riskfactors, such as low-density lipoprotein cholesterol (LDL), diastolic blood pressure (DBP), and body mass index (BMI). 0.96]), or BMI (TSAT: 1.18 [1.04-1.34];
Body mass index (BMI) ‘(weight (kg)/height (m) 2 ) was calculated and patients with BMI ≥30 kg/m 2 were categorised as obese. The mean BMI was 27.48±4.93 Methods In this observational study, we included patients presenting with STE-ACS undergoing primary percutaneous coronary intervention (PCI).
Background High pulse pressure (PP) and aortic root diameter (AoD) are hallmarks of arterial stiffness or vascular aging and they are considered as riskfactors for age-related cardiovasculardisease, including heart failure (HF).
A, Normal axillary lymph nodes measuring milla1cf Fri, 05/10/2024 - 08:12 May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting , fat-enlarged axillary nodes on screening mammograms can predict high cardiovasculardisease (CVD) risk, Type 2 diabetes (T2DM), and hypertension (HTN).
For this reason, the practice guidelines for treating obesity recommend screening adults for overweight and obesity using BMI, diagnosing and establishing treatment targets based on their weight-related complications, as well as using pharmacotherapy and surgery for appropriate patients.
Background:Hypertension (HTN) is a major riskfactor for cardiovasculardisease (CVD) and is the leading cause of morbidity and mortality globally, with a rise in prevalence in low and middle-income countries (LMIC). Median BMI was 27.6 Median systolic and diastolic blood pressure (BP) was 142.5 mmHg, respectively.
BACKGROUND:This study aimed to develop a risk-scoring model for hypertension among Africans.METHODS:In this study, 4413 stroke-free controls were used to develop the risk-scoring model for hypertension. Logistic regression models were applied to 13 riskfactors.
Participants with LVI were significantly older, male, Black, had higher BMI, and lower HDL. There was no significant difference in history of cardiovasculardisease events (6% versus 4%, p=0.143). LV apical circumferential strain>-10% may be a novel and quantitative stroke riskfactor.
An elevated Lp(a) is a common genetic factor that is independently and causally related to premature coronary artery disease. But we must always remember that most genetic riskfactors are probabilistic rather than deterministic in terms of risk. Atherosclerosis. 2017 Jan;256:47-52.
COSMOS tested a cocoa extract supplement and a multivitamin-mineral supplement against one another and a placebo for reducing the risk of cardiovasculardisease and cancer. This hypothesis was studied in a randomized controlled trial known as the COcoa Supplement and Multivitamin Outcomes Study or COSMOS.
The 2023 Almanac results derived from the Global Burden of Disease (GBD) and spanning 1990 to 2022, were recently published in the Journal of American College of Cardiology. Implications: a renewed focus on prevention, treatment, and control strategies is imperative to address the escalating burden of cardiometabolic risks.
The HEART Study is the world's first clinical trial investigating the use of genomic 'polygenic risk score (PRS) testing' to support the prevention of cardiovasculardisease ( CVD ) in National Health Service (NHS) clinical practice. Prevention is at the heart of what we do as GPs and risk assessment underpins that.
LH individuals also appear to have more cardiovasculardisease (CVD) related conditions like diabetes and cancer. Thus, the present study sought to test the hypothesis that vascular function and heart rate variability (HRV), both key indicators of CVD risk, would be lower in LH compared to RH individuals.
partially because its key riskfactor, high blood pressure, is a ‘silent killer,’ and most patients have no symptoms before their first heart attack or stroke. Among participants with baseline body mass index (BMI) above 30 kg/m2, 70.4% Eighty percent of heart attacks and strokes are preventable.
The greatest risk for a shortened life expectancy and early onset of diseases arises when you move from pre-diabetes to diabetes. A diagnosis of diabetes pulls forward the time you are likely to develop cardiovasculardisease by a whopping ten years 6. All of these patients had a BMI >27.
Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major riskfactor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2. to 25 kg/m2) and underweight (BMI less than 18.5
They get the diseases of ageing about 20 to 25 years later than everyone else. It’s not that they don’t get cardiovasculardisease, cancer or dementia; they just get it way later than everyone else. Most adults, healthy centenarians included, will die from one of three things: CardiovascularDisease.
The prevalence of obesity has been rising faster than most other known modifiable riskfactors. In a Global Burden of Disease analysis, the prevalence of obesity was found to have doubled in more than 70 countries from 1980 to 2013. 1 This makes cardiovascularrisk management a priority goal in people with obesity.
An overview of findings, presented by the Menlo Park, CA-based company, which offers a cardiovascular digital health program, follows. months, participants with baseline body mass index (BMI) above 30 kg/m2 lost 12 pounds, or 5.1% The Hello Heart monitor and app recorded BP, heart rate, and the appearance of irregular heartbeat.
But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovasculardiseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. In short — do both!
But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovasculardiseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. In short — do both!
Patients were categorized into a metabolically healthy obese MHO+ve cohort, BMI> 30, and MHO-ve cohort, BMI<30. Trends, demographics, comorbidities, and outcomes were then compared between the two cohorts.Results:Overall Prevalence of stroke was higher in the MHO-ve cohort (2.4%
Share JUPITER In 2008 a landmark paper was published showing that in people without cardiovasculardisease and relatively normal LDL-cholesterol (<3.4 mmol/l or 130 mg/dl), the use of rosuvastatin 20mg significantly reduced the likelihood of major cardiovascular events 1. Share But what about events? What To Do?
Cardiovasculardisease, cancer and dementia account for 60% of all deaths in the US. Yes, many external factors impact these factors, but ultimately, you have significant control over all of these. Let’s look at what happens to NCD risk when these riskfactors are optimised.
We've known for a long time that smoking tobacco is linked to heart disease, and this study is evidence that smoking cannabis appears to also be a riskfactor for cardiovasculardisease, which is the leading cause of death in the United States,” Jeffers said.
The estimated relative risk reduction of MACE was 20% vs placebo (HR 0.80 [95% CI: 0.72, 0.90] p 1,2 The reduction of MACE with Wegovy was not impacted by age, sex, race, ethnicity, baseline BMI, or level of renal function impairment. Between 1999 and 2020, obesity-related cardiovasculardisease deaths tripled in the U.S.,
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content